Patents by Inventor Simina Crina PETROVAN

Simina Crina PETROVAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210062156
    Abstract: This invention relates to recombinantly-expressed denosumab molecules and methods for modulating glycan profiles of denosumab molecules.
    Type: Application
    Filed: April 30, 2019
    Publication date: March 4, 2021
    Applicant: Amgen Inc.
    Inventors: Christopher Kenyon CROWELL, Jian W U, Athena Denise NAGI, Neil KITCHEN, Alison Jean GILLESPIE, Simina Crina PETROVAN, Michael Charles BRANDENSTEIN
  • Publication number: 20200087698
    Abstract: The present invention relates to methods of modulating the mannose content of recombinant proteins.
    Type: Application
    Filed: October 16, 2019
    Publication date: March 19, 2020
    Applicant: AMGEN INC.
    Inventors: Jian WU, Sean DAVERN, Simina Crina PETROVAN, Michael Charles BRANDENSTEIN, Katherine Rose LINDAHL, Shawn Erik LILLIE
  • Publication number: 20180002733
    Abstract: The present invention relates to methods of modulating the mannose content of recombinant proteins.
    Type: Application
    Filed: July 17, 2017
    Publication date: January 4, 2018
    Applicant: Amgen Inc.
    Inventors: Jian WU, Sean DAVERN, Simina Crina PETROVAN, Michael Charles BRANDENSTEIN, Katherine Rose LINDAHL, Shawn Erik LILLIE
  • Patent number: 9822388
    Abstract: The present invention relates to methods of modulating the mannose content of recombinant proteins.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: November 21, 2017
    Assignee: Amgen Inc.
    Inventors: Jian Wu, Sean Davern, Simina Crina Petrovan, Michael Charles Brandenstein, Katherine Rose Lindahl, Shawn Erik Lillie
  • Publication number: 20160032343
    Abstract: The present invention relates to methods of modulating the mannose content of recombinant proteins.
    Type: Application
    Filed: March 10, 2014
    Publication date: February 4, 2016
    Applicant: AMGEN INC.
    Inventors: Jian WU, Sean DAVERN, Simina Crina PETROVAN, Michael Charles BRANDENSTEIN, Katherine Rose LINDAHL, Shawn Erik LILLIE